title: Factors predicting recurrent endometrial cancer.
abstract: OBJECTIVE
  The aim of this study was to identify (prognostic) factors that may predict the development of recurrent endometrial cancer and may improve the choice of adjuvant therapy subsequently.
  
  
  METHODS
  Data of all patients, diagnosed with primary endometrial cancer in Orbis Medical Center Sittard between 2002 and 2010, were analyzed retrospectively. Cox regression analysis was performed for identification of independent prognostic factors; survival was calculated by using the Kaplan-Meier method.
  
  
  METHODS
  Data of all patients, diagnosed with primary endometrial cancer in Orbis Medical Center Sittard between 2002 and 2010, were analyzed retrospectively. Cox regression analysis was performed for identification of independent prognostic factors; survival was calculated by using the Kaplan-Meier method. Multiple factors were associated with recurrence. Age, histological type and progesteron receptor expression (PR) were identified as independent prognostic factors. Risk profile (according to the PORTEC-1 study) and PR were also independent prognostic factors. Furthermore, PR (p < 0.001) and histological type (p = 0.013) were associated with disease specific survival after recurrence.
  
  
  CONCLUSIONS
  Although the survival of endometrial cancer is good, the prognosis of recurrent disease is poor. Recurrence- of endometrial cancer and disease free survival rates are associated with several (independent) factors. The effect of adjuvant treatment may improve through more sufficient selection of patients by using the new prognostic- factors and through better selection of the type of adjuvant therapy.
  
  
  BACKGROUND
  Endometrial cancer, recurrence, survival, prognostic factors, progesterone receptor expression.
authors.affiliation: Resident, MSc, Dept. Gynecology and Obstetrics, Orbis Medical Center, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, the Netherlands.
authors.forename: A N J
authors.initials: AN
authors.lastname: Huijgens
authors.affiliation: Gynaecologist, PhD, MD, Dept. Gynecology and Obstetrics, Orbis Medical Center, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, the Netherlands.
authors.forename: H J M M
authors.initials: HJ
authors.lastname: Mertens
keywords: Endometrial cancer; progesterone receptor expression; prognostic factors; recurrence; survival
references.citation: Acta Obstet Gynecol Scand. 2008;87(2):240-6
references.pmid: 18231895
references.citation: Gynecol Oncol. 2010 Dec;119(3):506-10
references.pmid: 20837356
references.citation: J Med Assoc Thai. 2008 Dec;91(12):1779-84
references.pmid: 19133508
references.citation: Int J Radiat Oncol Biol Phys. 1989 Jul;17(1):21-7
references.pmid: 2745195
references.citation: Gynecol Oncol. 2006 Jun;101(3):520-9
references.pmid: 16556457
references.citation: Int J Cancer. 2010 Dec 15;127(12):2893-917
references.pmid: 21351269
references.citation: Clin Radiol. 2007 Jan;62(1):28-34; discussion 35-6
references.pmid: 17145260
references.citation: Lancet. 2000 Apr 22;355(9213):1404-11
references.pmid: 10791524
references.citation: Int J Gynaecol Obstet. 2009 May;105(2):103-4
references.pmid: 19367689
references.citation: Int J Gynaecol Obstet. 2008 May;101(2):205-10
references.pmid: 18199437
references.citation: Obstet Gynecol. 2005 Aug;106(2):413-25
references.pmid: 16055605
references.citation: Gynecol Oncol. 2009 Feb;112(2):342-7
references.pmid: 19062082
references.citation: Int J Gynecol Cancer. 2011 Aug;21(6):1078-83
references.pmid: 21633304
references.citation: Eur J Obstet Gynecol Reprod Biol. 2007 Jan;130(1):114-20
references.pmid: 16460871
references.citation: J Gynecol Oncol. 2011 Mar 31;22(1):3-8
references.pmid: 21607089
references.citation: Gynecol Oncol. 2012 Sep;126(3):466-73
references.pmid: 22609107
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1132-42
references.pmid: 15894663
references.citation: J Natl Cancer Inst. 2013 Aug 7;105(15):1142-50
references.pmid: 23781004
references.citation: Trends Endocrinol Metab. 2011 Apr;22(4):145-52
references.pmid: 21353793
references.citation: Int J Gynecol Cancer. 2003 Jul-Aug;13(4):458-65
references.pmid: 12911722
references.citation: Med Oncol. 2006;23(4):543-8
references.pmid: 17303913
references.citation: Int J Gynaecol Obstet. 2000 Aug;70(2):209-62
references.pmid: 11041682
references.citation: J Pathol. 2005 Apr;205(5):597-605
references.pmid: 15726651
references.citation: Lancet. 2005 Aug 6-12;366(9484):491-505
references.pmid: 16084259